GlassScriptPhysician profile
Dan Duc Nguyen
NPI 1205127610
$4,562.90
in general payments reported to CMS, 2019-2025
11 companies · $2,474 in 2025
The $2,474 reported for 2025 was more than what 76% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $123 · 2022: $121 · 2023: $347 · 2024: $1,382 · 2025: $2,474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,203.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,117.44 | 2024-2025 | Penumbra System, Red 72, Benchmark |
| Route 92 Medical, INC. | $680.02 | 2025 | |
| Scientia Vascular | $629.65 | 2024 | Plato 17 |
| Imperative Care, INC | $588.81 | 2023-2025 | Zoom 88-T Large Distal Platform |
| Depuy Synthes Sales INC. | $455.40 | 2023-2025 | Emboguard, Embotrap, Trufill |
| Stryker Corporation | $322.76 | 2025 | Surpass Evolve, Evolve |
| Medtronic, INC. | $277.49 | 2023-2025 | Pipeline, Solitaire X |
| Portola Pharmaceuticals, LLC | $238.83 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $120.75 | 2022 | |
| Qapel Medical INC | $103.89 | 2025 | |
| Janssen Biotech, INC. | $27.86 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.